Rafferty Asset Management’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
80,228
+8,802
| +12% | +$229K | 0.01% | 599 |
|
|
2025
Q1 | $1.75M | Sell |
71,426
-7,295
| -9% | -$179K | 0.01% | 610 |
|
|
2024
Q4 | $2.26M | Buy |
78,721
+126
| +0.2% | +$3.61K | 0.01% | 621 |
|
|
2024
Q3 | $2.97M | Buy |
78,595
+27,630
| +54% | +$1.04M | 0.01% | 540 |
|
|
2024
Q2 | $1.61M | Buy |
+50,965
| New | +$1.61M | 0.01% | 702 |
|